The crosstalk between ubiquitination and GlcNAcylation of CHAF1A regulates HIV-1 latency and reactivation
Journal of Virology · 23.12.2025 · 99 (12)
DOI: 10.1128/jvi.01518-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, erschienen am 23.12.2025. Verfasst von Tao Yang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Key Laboratory for Systems Medicine in Inflammatory Diseases, Centre for Infection and Immunity Study (CIIS), School of Medicine, Shenzhen C…. Hauptthemen laut MEDLINE: Virus Latency, HIV-1, Virus Activation, HIV Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Shenzhen Municipal Science and Technology Innovation Council | Shenzhen Science and Technology Innovation Program ().
Abstract (Originalsprache)
The persistence of latent HIV-1 reservoirs remains a critical barrier to cure. Current “shock and kill” strategies are limited by ineffective latency-reversing agents (LRAs) and poor understanding of epigenetic regulation. Here, we identify chromatin assembly factor 1 subunit A (CHAF1A), a histone chaperone enforcing HIV-1 latency, as a therapeutic target regulated by antagonistic post-translational modifications: ubiquitination promotes its degradation, while O-GlcNAcylation stabilizes it. We demonstrate that trifluridine, a Food and Drug Administration-approved antiviral drug, reactivates latent HIV-1 by disrupting O-GlcNAcylation, triggering CHAF1A ubiquitination and proteasomal degradation. Notably, CHAF1A expression increases with age in CD4 + T cells (>60 years), correlating with deeper proviral reservoirs. This age-dependent accumulation inversely associates with reduced O-GlcNAcase levels, suggesting O-GlcNAcylation-mediated stabilization in aging. Our findings establish CHAF1A as both a therapeutic target and an age-stratifying biomarker, advancing trifluridine as a translatable LRA to enhance reservoir clearance in aging populations—a demographic increasingly impacted by HIV-1 persistence. IMPORTANCE HIV-1 latency continues to represent a significant barrier to achieving a cure, particularly in aging populations characterized by expanded viral reservoirs and compromised immune recovery—a challenge further intensified by the absence of therapies specifically designed to target age-related mechanisms. Current latency-reversing agents (LRAs) are insufficient in addressing the metabolic and epigenetic dysregulation that sustains viral persistence in older individuals. In this study, we reveal a dynamic interplay between ubiquitination and O-GlcNAcylation that regulates the stability of CHAF1A, a histone chaperone essential for maintaining HIV-1 latency. We identify trifluridine as a novel LRA capable of disrupting O-GlcNAcylation to degrade CHAF1A, thereby effectively reversing latency in primary cells. This research bridges a critical gap between fundamental virology and clinical gerontology. These findings establish a robust foundation for refining strategies aimed at HIV-1 eradication, with a focus on targeting host metabolic-epigenetic networks to address latency in underserved aging populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shenzhen Key Laboratory for Systems Medicine in Inflammatory Diseases, Centre for Infection and Immunity Study (CIIS), School of Medicine, Shenzhen Campus of Sun Yat-Sen University, Sun Yat-Sen University, Shenzhen, Gua…
- Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
- Guangdong Institute of Intelligence Science and Technology, Hengqin, Zhuhai, Guangdong, China.
- Institute of Human Virology, Department of Pathogen Biology and Biosecurity, Key Laboratory of Tropical Disease Control of Ministry Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotech…
- Guangzhou Laboratory, Guangzhou International Bio-Island, Guangzhou, Guangdong, China.
- Department of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, Guangdong, China.
ORCID-Profile: Xiancai Ma, Hui Zhang, Linghua Li, Bingfeng Liu, Jie Qin, Ting Pan
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Shenzhen Municipal Science and Technology Innovation Council | Shenzhen Science and Technology Innovation Program ()
- Shenzhen Key laboratory of systems medicine and inflammatory diseases
- Important Key Program of Natural Science Foundation of China
- Key R&D Program of Department of Science and Technology of Guangdong
- Major Project of Guangzhou National Laboratory
Zitieren
APA
Yang, T., Chen, M., Zhou, M., Deng, X., Huang, P., Xie, S., Zeng, J., Luo, J., Zhang, Y., Ma, X., Sun, L., Liu, J., Zhang, H., Li, L., Liu, B., Qin, J., & Pan, T. (2025). The crosstalk between ubiquitination and GlcNAcylation of CHAF1A regulates HIV-1 latency and reactivation. Journal of Virology, 99(12). https://doi.org/10.1128/jvi.01518-25
Vancouver
Yang T, Chen M, Zhou M, Deng X, Huang P, Xie S, et al. The crosstalk between ubiquitination and GlcNAcylation of CHAF1A regulates HIV-1 latency and reactivation. Journal of Virology. 2025;99(12). doi:10.1128/jvi.01518-25
BibTeX
@article{Yang2025,
author = {Yang, Tao and Chen, Minghua and Zhou, Mo and Deng, Xiaohui and Huang, Peiming and Xie, Siyi and Zeng, Jianteng and Luo, Jingjing and Zhang, Yiwen and Ma, Xiancai and Sun, Liqin and Liu, Jiaye and Zhang, Hui and Li, Linghua and Liu, Bingfeng and Qin, Jie and Pan, Ting},
title = {The crosstalk between ubiquitination and GlcNAcylation of CHAF1A regulates HIV-1 latency and reactivation},
journal = {Journal of Virology},
year = {2025},
volume = {99},
number = {12},
doi = {10.1128/jvi.01518-25}
}
EUVIMED